Jonathan Bramson
Jonathan Bramson
Verified email at - Homepage
Cited by
Cited by
Interactions between the immune system and cancer: a brief review of non-spatial mathematical models
R Eftimie, JL Bramson, DJD Earn
Bulletin of mathematical biology 73, 2-32, 2011
TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection
A Zganiacz, M Santosuosso, J Wang, T Yang, L Chen, M Anzulovic, ...
The Journal of clinical investigation 113 (3), 401-413, 2004
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of …
JL Bramson, M Hitt, CL Addison, WJ Muller, J Gauldie, FL Graham
Human gene therapy 7 (16), 1995-2002, 1996
IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.
MJ Greenberger, SL Kunkel, RM Strieter, NW Lukacs, J Bramson, ...
Journal of immunology (Baltimore, Md.: 1950) 157 (7), 3006-3012, 1996
A human type 5 adenovirus–based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity
F Smaill, M Jeyanathan, M Smieja, MF Medina, N Thanthrige-Don, ...
Science translational medicine 5 (205), 205ra134-205ra134, 2013
Blood CD33 (+) HLA-DR (−) myeloid-derived suppressor cells are increased with age and a history of cancer
CP Verschoor, J Johnstone, J Millar, MG Dorrington, M Habibagahi, ...
Journal of leukocyte biology 93 (4), 633-637, 2013
Induction of epitope-specific neutralizing antibodies against West Nile virus
T Oliphant, GE Nybakken, SK Austin, Q Xu, J Bramson, M Loeb, ...
Journal of virology 81 (21), 11828-11839, 2007
Potentiating cancer immunotherapy using an oncolytic virus
BW Bridle, KB Stephenson, JE Boudreau, S Koshy, N Kazdhan, ...
Molecular Therapy 18 (8), 1430-1439, 2010
Maraba virus as a potent oncolytic vaccine vector
JG Pol, L Zhang, BW Bridle, KB Stephenson, J Rességuier, S Hanson, ...
Molecular therapy 22 (2), 420-429, 2014
Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination
Y Wan, J Bramson, R Carter, F Graham, J Gauldie
Human gene therapy 8 (11), 1355-1363, 1997
The use of adenoviral vectors for gene therapy and gene transfer in vivo
JL Bramson, FL Graham, J Gauldie
Current opinion in biotechnology 6 (5), 590-595, 1995
Defining the critical hurdles in cancer immunotherapy
BA Fox, DJ Schendel, LH Butterfield, S Aamdal, JP Allison, PA Ascierto, ...
Journal of translational medicine 9, 1-15, 2011
Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL
L Luketic, J Delanghe, PT Sobol, P Yang, E Frotten, KL Mossman, ...
The Journal of Immunology 179 (8), 5024-5032, 2007
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties
M François, R Romieu-Mourez, S Stock-Martineau, MN Boivin, ...
Blood, The Journal of the American Society of Hematology 114 (13), 2632-2638, 2009
A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo
EM Bertram, W Dawicki, B Sedgmen, JL Bramson, DH Lynch, TH Watts
The Journal of Immunology 172 (2), 981-988, 2004
IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice
FM Botelho, CMT Bauer, D Finch, JK Nikota, CCJ Zavitz, A Kelly, ...
PloS one 6 (12), e28457, 2011
Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines
J Bramson, K Dayball, C Evelegh, YH Wan, D Page, A Smith
Gene therapy 10 (3), 251-260, 2003
Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12
J Bramson, M Hitt, WS Gallichan, KL Rosenthal, J Gauldie, FL Graham
Human gene therapy 7 (3), 333-342, 1996
Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination
JL Bramson, M Hitt, J Gauldie, FL Graham
Gene therapy 4 (10), 1069-1076, 1997
The rational development of CD133-targeting immunotherapies for glioblastoma
P Vora, C Venugopal, SK Salim, N Tatari, D Bakhshinyan, M Singh, ...
Cell Stem Cell 26 (6), 832-844. e6, 2020
The system can't perform the operation now. Try again later.
Articles 1–20